Minzoya Kit
Product Images NDC 70748-322

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Minzoya (NDC 70748-322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (A9b53499 F087 42c3 903c 0e36de85c781 01)

A forest plot displaying effect estimates (including odds ratios, relative risks, and hazard ratios) with confidence intervals for various studies comparing combined oral contraceptive (COC) use versus never use. The studies range from 2002 to 2017 and include different cohorts; the plot visually presents the effect estimates with horizontal lines representing confidence intervals centered around a vertical reference line at 1.00.*

FDA Label Image

Levonorgestrel Usp And Ethinyl Estradiol Usp (A9b53499 F087 42c3 903c 0e36de85c781 02)

Chemical structure diagram showing Levonorgestrel USP and Ethinyl Estradiol USP, the active ingredients in MINZOYA. The structures depict molecular frameworks with labeled functional groups and stereochemistry information.*

FDA Label Image

Figure 2 (A9b53499 F087 42c3 903c 0e36de85c781 03)

Two pharmacokinetic graphs depicting concentration versus time for levonorgestrel and ethinyl estradiol. The upper chart shows levonorgestrel concentration (pg/mL) decreasing over 96 hours. The lower chart shows ethinyl estradiol concentration (pg/mL) also decreasing over 96 hours, both with data points and error bars.*

FDA Label Image

Image (A9b53499 F087 42c3 903c 0e36de85c781 04)

FDA Label Image

Figure (A9b53499 F087 42c3 903c 0e36de85c781 05)

An illustration showing a vertical scale of pregnancy rates per 100 women per year, from fewer than 1 to 85 or more pregnancies. Adjacent boxes list birth control methods categorized by effectiveness: top methods (implants, injections, intrauterine devices, sterilization), birth control pills and hormonal methods (skin patch, vaginal ring with hormones), barrier methods (condoms, diaphragm), other methods (no sex during fertile days, spermicide, withdrawal), and no birth control at the bottom.*

FDA Label Image

Figure A (A9b53499 F087 42c3 903c 0e36de85c781 06)

An instructional diagram for the MINZOYA kit, showing a 28-day pill calendar arranged by week and day. Weeks 1 to 3 contain white to off-white active pills, and week 4 contains blue inactive pills. Arrows indicate the direction of pill intake from left to right each week, starting on Sunday.*

FDA Label Image

Figure B (A9b53499 F087 42c3 903c 0e36de85c781 07)

Illustration showing the weekly tablet regimen for the MINZOYA kit, indicating the sequence of taking active (white to off-white) and inactive (blue) tablets from left to right across four weeks, with days of the week labeled for each pill and directional arrows for usage guidance.*

FDA Label Image

Image (A9b53499 F087 42c3 903c 0e36de85c781 08)

FDA Label Image

Blister Label (A9b53499 F087 42c3 903c 0e36de85c781 09)

MINZOYA kit containing levonorgestrel, ethinyl estradiol, and ferrous bisglycinate tablets. The label shows monthly self-breast exam instructions, dosage details with active white tablets and inactive blue tablets for Week 1 through Week 4. Manufactured by Lupin Limited in India, the label includes storage instructions, lot number, expiration date fields, and a 28 tablet blister card layout for 4 weeks.*

FDA Label Image

Carton Label (A9b53499 F087 42c3 903c 0e36de85c781 10)

MINZOYA kit label for levonorgestrel and ethinyl estradiol and ferrous bisglycinate tablets, USP. The label shows the product strength as 0.1 mg/0.02 mg and 36.5 mg, with a 3-pack blister pack configuration containing 28 tablets each for a 28-day regimen. Labeler is Lupin Pharmaceuticals, Inc., with distribution and manufacturing information on the packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.